Home Dompe's investigational biotech molecule receives orphan drug...
 

Keywords :   


Dompe's investigational biotech molecule receives orphan drug...

2015-12-08 10:08:14| Biotech - Topix.net

The Dompe biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has officially designated recombinant human Nerve Growth Factor - the investigational biotech molecule developed by Dompe based on research by Nobel Laureate Rita Levi Montalcini - as an orphan drug for the treatment of neurotrophic keratitis. NGF is the first neurotrophic factor to be identified and purified, and represents one of the most interesting topics being studied in medicine today and specifically in ophthalmology.

Tags: drug receives biotech molecule

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
More »